Literature DB >> 12738948

Disparities in risk of and survival from oropharyngeal squamous cell carcinoma.

Craig S Miller1, Robert G Henry, Mary Kay Rayens.   

Abstract

BACKGROUND: Oropharyngeal cancer has a low 5-year survival rate in the United States, indicating that much remains to be learned about risk and survival factors. The purpose of this research was to identify factors that contribute to risk of and survival from this disease in a region associated with high tobacco use.
METHODS: A retrospective chart review of 221 subjects with diagnosis of head and neck cancer at a regional University Medical Center during a 10-year period (1986 to 1995) was performed to identify relationships between risk and survival factors of oropharyngeal squamous cell carcinoma (OSCC). Data from 92 records met the inclusion criteria and were analyzed with the chi(2) test of association, the Fisher exact test, and the log-rank test for comparison of survival distributions. The software used was SAS for Windows, release 8.2.
RESULTS: Most study subjects were white men between the ages of 50 and 75 years who chronically used tobacco and alcohol. The overall median survival period of the group was 18.1 months. The percentage of subjects surviving to 3 years was 35.6%. Disparities were identified in risk and survival by sex, race, age, dwelling, anatomic site, and exposure to carcinogenic substances. In particular, the disease more adversely affected minorities and those who chronically used tobacco or alcohol.
CONCLUSIONS: Our results show that, in the examined regional population, a high prevalence of tobacco use correlated with alcohol use and a lower rate of survival from OSCC than the national rate. Also, risk of and survival from OSCC are affected by demographic, geographic, and behavioral factors. This information is useful for the design and implementation of more effective preventive and intervention strategies.

Entities:  

Mesh:

Year:  2003        PMID: 12738948     DOI: 10.1067/moe.2003.108

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod        ISSN: 1079-2104


  8 in total

1.  Human papillomavirus-related squamous cell carcinoma of the oropharynx: a comparative study in whites and African Americans.

Authors:  Rebecca D Chernock; Qin Zhang; Samir K El-Mofty; Wade L Thorstad; James S Lewis
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2011-02

2.  Pretreatment health behaviors predict survival among patients with head and neck squamous cell carcinoma.

Authors:  Sonia A Duffy; David L Ronis; Scott McLean; Karen E Fowler; Stephen B Gruber; Gregory T Wolf; Jeffrey E Terrell
Journal:  J Clin Oncol       Date:  2009-03-16       Impact factor: 44.544

3.  Health behaviors predict higher interleukin-6 levels among patients newly diagnosed with head and neck squamous cell carcinoma.

Authors:  Sonia A Duffy; Theodoros Teknos; Jeremy M G Taylor; Karen E Fowler; Mozaffarul Islam; Gregory T Wolf; Scott McLean; Tamer A Ghanem; Jeffrey E Terrell
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-01-08       Impact factor: 4.254

Review 4.  A review of the epidemiology of oral and pharyngeal carcinoma: update.

Authors:  Daniel M Saman
Journal:  Head Neck Oncol       Date:  2012-01-13

5.  Protocol: systematic review of the association between socio-economic status and survival in adult head and neck cancer.

Authors:  Bilal G Taib; Joseph Rylands; Sue Povall; Terry M Jones; David Taylor-Robinson
Journal:  Syst Rev       Date:  2017-08-02

6.  Epidemiology and survival outcomes of lip, oral cavity, and oropharyngeal squamous cell carcinoma in a southeast Brazilian population.

Authors:  B-V Louredo; P-A Vargas; M-E Pérez-de-Oliveira; M-A Lopes; L-P Kowalski; M-P Curado
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2022-05-01

7.  USP22 is useful as a novel molecular marker for predicting disease progression and patient prognosis of oral squamous cell carcinoma.

Authors:  Songlin Piao; Yanlong Liu; Jing Hu; Fulin Guo; Jie Ma; Yao Sun; Bin Zhang
Journal:  PLoS One       Date:  2012-08-03       Impact factor: 3.240

8.  Validation of Next-Generation Sequencing of Entire Mitochondrial Genomes and the Diversity of Mitochondrial DNA Mutations in Oral Squamous Cell Carcinoma.

Authors:  Anita Kloss-Brandstätter; Hansi Weissensteiner; Gertraud Erhart; Georg Schäfer; Lukas Forer; Sebastian Schönherr; Dominic Pacher; Christof Seifarth; Andrea Stöckl; Liane Fendt; Irma Sottsas; Helmut Klocker; Christian W Huck; Michael Rasse; Florian Kronenberg; Frank R Kloss
Journal:  PLoS One       Date:  2015-08-11       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.